Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score.

BACKGROUND Genetic and environmental factors are involved in the pathogenesis of autoimmune thyroid disease (AITD). Family members of patients with AITD are at increased risk for AITD, but not all will develop overt hypothyroidism or hyperthyroidism. Our goal was to develop a simple predictive score that has broad applicability and is easily calculated at presentation for progression to overt hypothyroidism or hyperthyroidism within 5 years in female relatives of patients with AITD. METHODS We conducted a prospective observational cohort study of 790 healthy first- or second-degree female relatives of patients with documented Graves or Hashimoto disease in The Netherlands. Baseline assessment included measurement of serum thyrotropin (TSH), free thyroxine (FT(4)), and thyroid peroxidase (TPO) antibody levels as well as evaluation for the presence and levels of Yersinia enterocolitica antibodies. We also gathered data on family background, smoking habits, use of estrogen medication, pregnancy, and exposure to high levels of iodine. In follow-up, thyroid function was investigated annually for 5 years. As main outcome measures, termed events, we looked for overt hypothyroidism (TSH levels >5.7 mIU/L and FT(4) levels <0.72 ng/dL) or overt hyperthyroidism (TSH levels <0.4 mIU/L and FT(4) levels >1.56 ng/dL). RESULTS The cumulative event rate was 7.5% over 5 years. The mean annual event rate was 1.5%. There were 38 hypothyroid and 13 hyperthyroid events. Independent risk factors for events were baseline findings for TSH and TPO antibodies in a level-dependent relationship (for TSH the risk already starts to increase at values >2.0 mIU/L) and family background (with the greatest risk attached to subjects having 2 relatives with Hashimoto disease). A numerical score, the Thyroid Events Amsterdam (THEA) score, was designed to predict events by weighting these 3 risk factors proportionately to their relative risks (maximum score, 21): low (0-7), medium (8-10), high (11-15), and very high (16-21). These THEA scores were associated with observed event rates of 2.7%, 14.6%, 27.1%, and 76.9%, respectively. CONCLUSIONS An accurate simple predictive score was developed to estimate the 5-year risk of overt hypothyroidism or hyperthyroidism in female relatives of patients with AITD. However, in view of the small number of observed events, independent validation of the THEA score is called for.

[1]  D. Dazzi,et al.  Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. , 2006, The Journal of clinical endocrinology and metabolism.

[2]  L. Hegedüs,et al.  The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. , 2006, European journal of endocrinology.

[3]  M. Surks,et al.  The thyrotropin reference range should remain unchanged. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  L. Wartofsky,et al.  The evidence for a narrower thyrotropin reference range is compelling. , 2005, The Journal of clinical endocrinology and metabolism.

[5]  A. Morris,et al.  The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. , 2004, The Journal of clinical endocrinology and metabolism.

[6]  S. Pearce,et al.  Toward precise forecasting of autoimmune endocrinopathy. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  Y. Tomer,et al.  Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. , 2003, Endocrine reviews.

[8]  W. Wiersinga,et al.  Risk factors for and prevalence of thyroid disorders in a cross‐sectional study among healthy female relatives of patients with autoimmune thyroid disease , 2003, Clinical endocrinology.

[9]  Y. Tomer,et al.  Sibling recurrence risk in autoimmune thyroid disease. , 2003, Thyroid : official journal of the American Thyroid Association.

[10]  W. Wiersinga,et al.  Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease , 2003, Clinical and experimental immunology.

[11]  T. Jørgensen,et al.  Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey. , 2002, The Journal of clinical endocrinology and metabolism.

[12]  T. Mack,et al.  Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. , 2002, Thyroid : official journal of the American Thyroid Association.

[13]  W. Wiersinga,et al.  A survey of iodine intake and thyroid volume in Dutch schoolchildren: reference values in an iodine-sufficient area and the effect of puberty. , 2001, European journal of endocrinology.

[14]  L. Hegedüs,et al.  Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. , 2001, The Journal of clinical endocrinology and metabolism.

[15]  A population-based study of chronic autoimmune hypothyroidism in Danish twins. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.